If you liked this article you might like

AbbVie Stock Higher on Humira Patent Win
Momenta, Coherus BioSciences Are Both Good Options in the Biosimilar Space
AbbVie's Battle Royale
16 Biopharma Companies Besides Medivation That Are Attractive Targets